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Abstract
Microbes occupy almost every niche within and on their human hosts. Whether colonising the gut,
mouth or bloodstream, micro-organisms face temporal fluctuations in resources and stressors within their
niche but we still know little of how environmental fluctuations mediate certain microbial phenotypes,
notably antimicrobial resistant ones. For instance, do rapid or slow fluctuations in nutrient and antimi-
crobial concentrations select for, or against, resistance?
We tackle this question using an ecological approach by studying the dynamics of a synthetic and
pathogenic microbial community containing two species, one sensitive and the other resistant to an an-
tibiotic drug where the community is exposed to different rates of environmental fluctuation. We provide
mathematical models, supported by experimental data, to demonstrate that simple community outcomes,
like competitive exclusion, can shift to coexistence and ecosystem bistability as fluctuation rates vary.
Theory gives mechanistic insight into how these dynamical regimes are related.
Importantly, our approach highlights a fundamental difference between resistance in single species
populations, the context in which it is usually assayed, and in communities. While fast environmental
changes are known to select against resistance in single-species populations, here we show that they can
promote the resistant species in mixed-species communities. Our theoretical observations are verified
empirically using a two-species Candida community.
2
1 Introduction
Microbes live in complex and diverse communities colonising almost every niche within and on the human
body [1]. The gut, vagina and skin are known to contain diverse microbial communities that differ remark-
ably between host individuals [1]. We are also beginning to discover that microbes occupy sites thought
previously to be sterile, such as the womb [2].
The composition of microbial communities is affected by resources [3, 4, 5] and drugs [6], both of
which are subject to temporal fluctuations. For example, nutrient availability in the form of glucose con-
centration is known to vary in urine [7], gut [8] and blood with substantial daily variations [9, 10]. In
addition, clinicians vary drug dosing regiments [11, 12, 13] which can lead to fluctuations in drug con-
centrations within a host niche. Moreover, daily drug fluctuations can also arise when the majority of an
administered drug is recovered unchanged in a patient’s urine within 24 hours after administration of a
single dose [12, 14].
How do environmental fluctuations in resources and drug concentrations mediate drug-resistance within
a microbial community? It is increasingly recognised that antimicrobial resistance is an ecological as well
as a genetic problem [15, 16, 17] with sensitive and resistant species competing for limited nutrients. While
the expectation is that resistant species have a competitive advantage over sensitive ones in the presence of
a drug, empirical observations demonstrate that they can coexist [18, 19, 20]. What isn’t known is how this
coexistence as well as other possible competitive outcomes are influenced by fluctuating environments.
The limited understanding of microbial response to fluctuating environments comes in the majority
from single species studies. The selection for mutations in fluctuating environments has been extensively
studied in theory [21, 22, 23, 24, 25] showing that complex interactions between dynamics of the environ-
ment and dynamics of adaptation can affect selection. In addition, experimental studies have shown that
fluctuating environments have a profound effect on selection for antibiotic resistance [26, 27, 28] suggest-
ing that rapid fluctuations could avoid the evolution of resistance.
In the context of multi-species communities, the focus has mainly been on identifying conditions of
species coexistence in fluctuating environments, with some experimental [29] but mainly theoretical con-
siderations [30, 31, 32, 33, 34]. Here we ask a different question, do rapid or slow fluctuations of microbial
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nutrients and antimicrobials select for, or against antimicrobial resistance in a multi-species community?
To this end, we develop a model of the simplest possible community of two species, S and R, and
assume that the former is sensitive to an antimicrobial while the latter is resistant. The two species compete
for a limiting resource in the presence of the antimicrobial drug in a spatially homogeneous environment.
After a period of growth a small fraction of the population is transferred into a new environment containing
replenished resources and drugs.
The model is parameterised by Candida albicans and Candida glabrata growth data from [35]. C.
albicans and C. glabrata are members of healthy human microbiota, but in immunocompromised patients
can become pathogenic, leading not only to mucosal infections [36], but also life-threatening disseminated
infections [37]. Candidiasis is one of the top ten fungal diseases, which in total kill as many people each
year as tuberculosis or malaria [38]. Infections are associated with high mortality, especially bloodstream
candidiasis (46% to 75% [38, 39, 40]), and are difficult to diagnose. The majority of infections are caused
by C. albicans, however mixed-species infections with C. glabrata are increasing in occurrence [41]. Such
mixed-species infections are thought to be more severe and difficult to treat than single species infections
due to their dual pathogenic effect and the fact that C. glabrata is relatively unresponsive to the most
frequently used antifungal drug fluconazole [42, 43, 44].
Our model identifies regions that delineate resource and drug concentrations where competition be-
tween resistant and sensitive species gives rise to exclusion, bistability and coexistence. These regions are
shaped by the frequency of environmental fluctuations. In particular, we find regions for which a slow
rate of environmental change can promote the resistant species. In other regions, we find that the out-
come of competition can be independent of the fluctuation frequency. Finally, contrary to previous findings
for single species [26, 27], in certain environments, a fast rate of environmental fluctuation can support
the prevalence of resistance. We qualitatively verify these predictions using laboratory competitions be-
tween C. albicans and C. glabrata.
Our results highlight a fundamental difference between resistance in single species assays, the context
where it is always assayed, and resistance in microbial communities. In the latter, we show both that a
drug-susceptible species can be maintained in the presence of drug and that fast environmental changes
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that can mitigate resistance in single species studies [26, 27] can inadvertently promote growth of resistant
species in mixed-species communities. This is because the competition for fluctuating nutrients between
species, and therefore between two differing metabolic strategies, introduces an extra dimension which is
not considered in single species studies.
2 Materials and methods
2.1 Mathematical model of multi-species competition
Consider a microbial community consisting of two species, S and R, competing for a limiting nutrient, N.
S is assumed to be sensitive to an antimicrobial drug D, while R is resistant to it.
In our model, all cells take up an extracellular nutrient and convert it into adenosine-5’-triphosphate
(ATP) using a simple unbranched metabolic pathway [45, 46]. The rate of ATP production in the pathway
is given by qk⇥nATP,k, where qk denotes the rate of the pathway while nATP,k is the number of ATP units
produced per one unit of nutrient in the pathway. The subscript k takes the form k = S or k = R referring
to the sensitive or resistance species, respectively; this is represented mathematically as k 2 {S,R}.
As in [45, 46] we make a simplifying assumption that the behaviour of the entire pathway can be
modelled with Michaelis-Menten kinetics of a single reaction. Thus qk is the following function of the
concentration N of the limiting nutrient:
qk(N) =
Vmax,k⇥N
Km,k+N
, k 2 {S,R} , (1)
withVmax,k denoting the maximal rate of the pathway and Km,k representing the Michaelis-Menten constant
corresponding to the species k 2 {S,R}. The pathway rate qk(N) represents the rate at which the product is
formed which in this case is the same as the rate at which the nutrient is consumed. Therefore, throughout
this paper we refer to Vmax,k as the maximal rate of nutrient uptake and Km,k as the measure of affinity for
a nutrient corresponding to the species k 2 {S,R}.
If microbes are limited by their energetic resource, the amount of biomass formed per unit of ATP is
approximately constant and does not depend on the model of ATP production [47]. Thus, as highlighted
by [48], if the rate of ATP production increases, the rate of biomass formation and thus the growth rate
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of an organism increases. Therefore, in our model the growth rate is represented as a linear function of
of the rate of ATP production, namely Gk⇥ qk(N)⇥ nATP,k, with Gk denoting a proportionality constant
and k 2 {S,R}.
The influence of the drug is modelled as a reduction in growth as suggested elsewhere [35] and we
briefly summarise the assumptions here. First, we assume that drug growth suppression is the accumulation
of processes that decrease per capita growth rate in a non-linear and concentration-dependent manner, with
greater inhibition at higher drug concentrations. Second, we assume that the inhibitory effect of the drug
on growth depends only on the intracellular accumulation of the drug. Therefore, as in [35], we represent
reduction in growth by a function 0 i(Din,S) 1 which takes the form:
i(Din,S) = 1  a⇥ (Din,S)
c
bc+(Din,S)c
, (2)
where Din,S is the intracellular concentration of the drug in S, measured in pmol/ml. The parameters a, b,
and c describe individual properties of S related to its sensitivity to the drug.
In may be instructive to note that the concentration of S cells is not incorporated explicitly into the
inhibition function i(Din,S) which, as a result, only depends on the quantity of internalised drug per ml and
not drug per cell. Thus, inhibition due to drug is not measured here per cell but is instead measured per
target per ml inside the cell, assuming those drug targets are sufficient in number and sufficiently diffuse
inside cells that their concentration (in ml) can be defined and that this is homogeneous throughout the cell.
Since R is resistant to the drug, there is no drug-induced reduction in its growth and hence we set i(Din,R)=
1. For simplicity we do not model the resistance mechanism explicitly. Moreover, we assume no horizontal
gene transfer of resistance between the two species.
Third, we assume that drug import is a saturating function of the extracellular drug concentration (Dex)
which takes the form:
I(Dex) =
Vi,k⇥Dex
Ki,k+Dex
, k 2 {S,R} , (3)
where Vi,k represents the maximum drug import rate related to the species k, and Ki,k denotes the concen-
tration of the drug at the half-maximal import rate for this species. Finally, we assume that the saturating
drug import function is balanced by a saturating drug export function (as observed in [49, 35]) and that the
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rate of export is dependent on the intracellular drug concentration in the following way:
E(Din,k) =
Ve,k⇥Din,k
Ke,k+Din,k
, k 2 {S,R} , (4)
where Ve,k is the maximum drug export rate related to the species k, and Ke,k represents a half-saturation
constant for this species.
The dynamics of competition between S and R within a single season begins with the introduction of
the drug (Dex) and the limiting nutrient (N) while observing the concentration of both species (XS and
XR) in the environment. Note that XS and XR here represent concentrations per ml of unspecified volume
but measurable mass. One season of competition of length T is described by the following differential
equation: 8>>>>>>>>>>>>>>>>>>>>>><>>>>>>>>>>>>>>>>>>>>>>:
N˙(t) = qS(N(t))⇥XS(t) qR(N(t))⇥XR(t)
D˙ex(t) = (E(Din,S(t))  I(Dex(t)))⇥XS(t)+(E(Din,R(t))  I(Dex(t)))⇥XR(t)
D˙in,S(t) = (I(Dex(t)) E(Din,S(t)))⇥XS(t)
D˙in,R(t) = (I(Dex(t)) E(Din,R(t)))⇥XR(t)
X˙S(t) = GS⇥qS(N(t))⇥nATP,S⇥XS(t)⇥ i(Din,S(t))
X˙R(t) = GR⇥qR(N(t))⇥nATP,R⇥XR(t)
t 2 [0,T ] (5)
The model is parametrised using a system of two human pathogenic species Candida albicans and Can-
dida glabrata in the presence of an antimicrobial drug fluconazole (see Supplementary Fig 1 and Supple-
mentary Table 1 for details).
We will explore the dynamics of competition over multiple seasons of growth by representing (5) as
a discrete dynamical system, F, in the following way. At the end of a growth season of length T , a
fixed measure of biomass is transferred to a new environment containing replenished growth medium with
limiting nutrient concentration N and drug Dex; these are also fixed at the same concentrations at the start
of each season. This creates a 1-season map, F( f ;T,m,n) where f = XS(0)/(XS(0)+XR(0)) is the initial
frequency of S at the start of a season and we solve (5) forwards for T units of time with Dex(0) = m
and N(0) = n. For simplicity, we assume Din,k(0) = 0 for k 2 {S,R} and we remark on this assumption
7
below. Given this, F( f ;T,m,n) = XS(T )/(XS(T )+XR(T )) which is the frequency of S after the season
of growth has finished. Repeated applications of F to initial frequencies of S can be used to determine C.
albicans frequency after any number of seasons j, which is typically written f j = F( f j 1;T,m,n) when
f0 is known and (T,m,n) is a vector of parameters that may alter the dynamics induced by F if they
change. This dynamical systems approach to modelling seasonal microbial populations has been used
elsewhere [35, 52].
The assumption that Din,k(0) = 0 is needed so that the discrete dynamical system, F, is a well-defined
single-season map acting on a 1-dimensional variable f . If this condition on the internal drug concentration
were not met, that concentration would also need to be tracked by F, making it a 2-dimensional map
of a 2-dimensional variable. To avoid this complication, we use this assumption that has the biological
interpretation of microbes, that have active drug export systems, being washed free of drug before a new
season begins.
As (5) has no concept of cell volume but it can represent biomass, we need a rationale for relating
modelled outputs to empirical data where measures may be made on a per cell basis. Therefore, we convert
biomass predictions from (5) into cell concentration quantities by making the assumption that empirically
determined biomass (optical density (OD), see Supplementary Fig. 1) has a single and fixed conversion
parameter that is a proxy for the number of cells per unit of biomass.
The above seasonal dynamic defined by F mimics a common experimental protocol known as ‘batch
culture’ but there are other protocols and so, to compare the behaviour of (5) with its equivalent in a
chemostat environment, we modified (5) as described in Supplementary Section 4 to have a constant flow
of nutrients. Finally, we remark that growth within a single season is dynamic and not necessarily in
equilibrium whereas F could have itself achieved equilibrium by approaching a fixed point f ⇤, where
f⇤ =F( f⇤).
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2.2 Experimental materials and methods
2.2.1 Strains and medium
The Candida albicans strain ACT1-GFP was used, which is the SBC153 strain tagged with GFP at the
ACT1 locus using a nourseothricin resistance cassette [50]. The wild-type Candida glabrata reference
strain ATCC2001 was used. Each strain was streaked from glycerol stocks onto YPD agar and incubated
for 2 days at 30 C. A stock solution of fluconazole was prepared at 2 mg/ml in DMSO, stored at  20 C
and diluted into medium as necessary. Experiments were performed in synthetic complete (SC) media
(0.67% w/v yeast nitrogen base without amino acids, 0.079% w/v synthetic complete supplement mixture
(Formedium, UK)).
2.2.2 Competitions in varying glucose and fluconazole
Overnight cultures of C. albicans or C. glabrata were prepared by inoculating a single colony into 5 ml of
synthetic complete (SC) medium containing either 0.025%, 0.05%, 0.1%, or 0.5% glucose (weight/volume)
and incubating at 30 C and 180 rpm for 16 – 18 hours. Overnight cultures were then mixed to achieve a
range of 12 initial fractions of C. albicans. Note that this protocol is different from that of Fig. 1b in [35],
where overnights were performed in YPD and at a different initial density.
Fluconazole (0, 0.5 µg/ml or 2 µg/ml) was added to SC medium containing either 0.025%, 0.05%,
0.1%, or 0.5% glucose (the same % as in the overnight cultures) and a volume of 145 µl added to the wells
of a 96-well flat bottom microtiter plate. Each mixed cell suspension was added (5 µl) to six wells making
a total volume of 150 µl in each well (72 wells in total). This resulted in a dilution from the overnights
of ⇥30 allowing a maximum of log2(30) ⇠ 4.9 generations of growth until stationary phase. Plates were
sealed with adhesive films and two holes were punched above each well with a sterile needle to allow
air flow. Plates were incubated at 30 C and 350 rpm for 24 hours. C. albicans is a polymorphic fungus,
able to grow as yeast, pseudohyphae or hyphae. The growth conditions used were crucial in maintaining
it as yeast and therefore allowing a consistent form of quantification across a range of nutrient and drug
concentrations.
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2.2.3 Flow cytometry measurements
The fraction of each strain in the initial mixtures was determined using flow cytometry. Samples were
prepared by adding 5 µl of each mixture to 145 µl of sterile DI water in the wells of a 96-well flat bottom
microtiter plate, following the protocol of the test cultures but replacing the medium with water. These
suspensions were diluted as necessary in DI water (2⇥, 3⇥ or 10⇥) to achieve 5⇥ 104  5⇥ 105 cell/ml
for measurement.
To measure the fraction of C. albicans in samples after 6 hours the contents of three of the six replicate
mixtures were pipetted vigorously and 30 µl removed for dilution with DI water. The plate was returned
to the incubator and the same protocol was repeated with the remaining untouched wells at 24 hours.
A Guava easyCyte HT System using Guava InCyte software (Merck Millipore) was used for flow
cytometry to record 5000 events. Using a FSC - SSC plot, events were gated and then strains separated
according to their GFP expression (excitation laser (525/30 nm)), to calculate the frequency of C. albicans
(Supplementary Fig 7). Three wells containing diluted SC medium in water were measured at the end of a
run of samples to record the number of false positives in each gate, the averages of which were subtracted
from the numbers measured for each test sample. Debris in the medium appears predominately within
the gated region for C. glabrata. Without this blanking procedure axenic samples of C. albicans typically
returned 95 – 100% of events in the gated region. Once blanked, this increased to 98 – 100%.
3 Results
We begin by theoretically exploring the behaviour of the system (5). In the absence of drug, our model
predictions are consistent with previous competition models [35] parametrised by the same experimental
system of two Candida species (Supplementary Section 1). In particular, S outcompetes R at low resource
concentrations, while the opposite happens at high resource concentrations (see Supplementary Section 2
for details).
Subsequently, we find that for short growth season length (small T ), R outcompetes S over a greater
range of initial resource concentrations than when season length is long (large T ), see Supplementary
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Fig 2. As the limiting resource is replenished to its original levels at the beginning of each season, shorter
season lengths enable the resource to remain at higher concentrations than when season lengths are longer,
thus favouring R. We also find that high population densities favour S for most season lengths, with R
having an advantage only at sufficiently high initial resource concentrations (see Supplementary Fig 2 and
Supplementary Table 2 for details).
In the presence of drug, introduced into the environment at a fixed concentration at the beginning of
each season, the outcome of competition between S and R is illustrated in Fig 1. In particular, for a given
drug concentration there are four possible outcomes depending on T and initial concentration of resources:
S always outcompetes R (light blue region in Fig 1); R always outcompetes S (gray region in Fig 1); either
species can outcompete the other depending on the initial frequency (brown region in Fig 1), and both
species can coexist (dark blue region in Fig 1).
The outcome of competition between S and R also changes with the drug concentration in the environ-
ment. Fig 2 illustrates a dose-response mosaic (as introduced in [35]) showing the outcome of competition
as a function of initial nutrient and drug concentrations as well as how this dose-response mosaic changes
for different T . Coexistence between S and R is predicted for both small and large T across a range of drug
concentrations, for initial nutrient concentrations at which the S species wins without the drug. This range
of nutrient concentrations moves higher as T increases.
Interestingly, we observe three qualitatively different outcomes regarding the relationship between re-
sistance and T . First, for environmental conditions with sufficiently high initial drug concentration and suf-
ficiently low initial resource concentration, increasing T can promote resistance (black squares). Second,
the outcome of competition can be independent of T . This is shown in Fig 2 for environmental conditions
with intermediate initial drug concentrations and sufficiently high initial resource concentrations (black
triangles). In this case the resistant competitor wins, regardless of T . Finally, we observe that decreasing T
can promote resistance. This is shown in Fig 2 for environmental conditions with sufficiently low initial
drug concentration and intermediate initial resource concentration (black circles). Qualitatively equiva-
lent theoretical results (across slightly different timescales) have been observed in a modelled chemostat
environment (cf. Supplementary Fig 6).
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Next we seek qualitative confirmation of the trends observed using (5), and F, by conducting competi-
tion experiments between the sensitive species C. albicans (S) and the resistant species C. glabrata (R) and
monitoring their relative frequencies. For this we co-cultured both species in shaken, 96-well plates con-
taining liquid growth media supplemented with glucose and fluconazole. The plates were inoculated with a
mixture of fluorescently labelled C. albicans, at proportion f , and C. glabrata, at proportion 1  f . After a
fixed growth time T (one season) densities and frequencies of each species were determined using flow cy-
tometry (see Section 2.2). The outcomes of competition were subsequently determined by deploying ideas
from microbial population biology [51] and dynamical systems theory, as previously done in [35, 52]. In
particular, population dynamics theory states that one can deduce multi-season frequency dynamics from
the ‘cobweb diagram’ determined from the initial C. albicans frequency plotted versus the final frequency
each season, as we further explain.
The shape of the function F( f ) describing a ’single-season frequency change map’ for the fixed season
length T , the initial drug concentration m and the initial nutrient concentration n (as described in Section
2.1) subsequently determines the outcome of competition [35] with Fig 3 illustrating possible outcomes.
Namely, if for each f between 0 and 1, F( f ) lies above the diagonal line denoted by F( f ) = f (Fig 3,
dotted line), then any initial frequency of S will increase over a single season. Thus the fraction of S in the
population will increase over multiple seasons until it reaches 1, meaning S wins the competition (Fig 3(a)).
If for each f between 0 and 1,F( f ) lies below the diagonal line then any initial frequency of S will decrease
over a single season. Thus the fraction of S in the population will decrease over multiple seasons until it
reaches 0, meaning the resistant species (R) wins the competition (Fig 3 (b)). If there exists an f between 0
and 1 for whichF( f ) crosses the diagonal, two outcomes are possible: coexistence between S and R (Fig 3
(c)) or bistable exclusion where either species can win depending on their initial frequency (Fig 3 (d)).
Experimentally generated ‘cobweb diagrams’ for different resource and drug concentrations and season
lengths are presented in Fig 4, showing qualitative agreement with the model predictions. In particular,
consistent with the model prediction (Fig 2 (a, b), gold and red squares marked A), in the absence of drug,
S outcompetes R when T is large, while this is not the case for small T (Fig 4, A). This is observed by
noting that the red cobweb diagram is significantly above the diagonal for all initial frequencies (see also
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Fig 3 (a) for a theoretical explanation), while this is not the case for the gold cobweb diagram.
Moreover, as predicted by the model (Fig 2 (a, b), gold and red squares marked B), for certain resource
and drug concentrations, T has little or no effect on the outcome of competition (Fig 4, B). In that case,
R outcompetes S for both long and short season lengths, this can be observed in Fig 4, B, by noting that
both gold and red cobweb diagrams are significantly below the diagonal (also see Fig 3 (b) for a theoretical
explanation).
Our data also recovers the result predicted by the model that, in the presence of drug, decreasing T
favours the resistant species (Fig 4, C, D, E and F). In that case, for large T , R is unable to completely
outcompete S, this can be observed in Fig 4, C, D and E by noting that for low initial frequencies red
cobweb data is not significantly below the diagonal (negative frequency dependence), indicating possible
coexistence between S and R (see Fig 3 (c) for a theoretical explanation), which is also observed in our
model Fig 2 (b) (C, D, and E red squares). However, when T is small, R outcompetes S, which is observed
in Fig 4, C, D, and E, by noting that for all initial frequencies gold cobweb data is significantly below the
diagonal (also see Fig 3 (b) for a theoretical explanation). This mimics the model predictions shown in
Fig 2 (a) (C, D, and E gold squares).
4 Discussion
Our study shows that a simple mathematical model of a two-species microbial community where a drug-
sensitive and a drug-resistant species compete for a limited nutrient in the presence of a drug, is capable
of capturing a rich diversity of competition outcomes, namely, coexistence, competitive exclusion, and
bistability. Temporal fluctuations in nutrient and drug concentrations readily experienced in natural envi-
ronments shape the regions of parameter space for which different competition outcomes are observed over
time (Fig 2).
Considering environmental fluctuations is important. Micro-organisms face changes in the concentra-
tion of antibiotics during chemotherapeutic treatments, with clinicians varying dosing regimens [11, 12,
13]. Similarly, concentrations of antibiotics change in the environment as antimicrobial compounds are re-
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leased by clinical, veterinary, or agricultural practices [53]. Micro-organisms also face changes in nutrient
availability at all environmental scales [54]. Glucose concentrations in the blood of critically ill patients
can have substantial daily variations [9, 10], while similar rapid fluctuations in dissolved organic carbon
are observed in marine environments [55].
Our model achieves good qualitative agreement with empirical observations and its simplicity enables
us to probe mechanisms driving the different competition outcomes. The model was parametrised using
growth data on clinical isolates of C. albicans and C. glabrata species. The two species have different
metabolism [56] and a previous study showed that, in the absence of drug, this can lead to complex,
density- and frequency-dependent ecological interactions such as cheating and cooperation [57]. Here we
found that differences in metabolism can enable C. albicans to outcompete C. glabrata at low resource
concentrations, while the opposite can happen at high resource concentrations. Increasing glucose con-
centration has a higher impact on the relative fitness of S when S is rare than when common, leading to a
region of nutrient concentrations characterised by bistability situated between the regions of competitive
exclusion. The resource concentration sufficient to support one species over the other depended on the
frequency of environmental fluctuations introduced here through changes in the length of the growing sea-
son. For short season lengths C. glabrata outcompeted C. albicans over a greater range of initial resource
concentrations than when the length of the growing season was longer (Supplementary Fig 2). Short season
lengths lead to a reduced wavelength of fluctuating resource concentration, enabling resources to remain at
higher concentrations than when the season length was longer, thus favouring C. glabrata, which is better
adapted to growth at high resource concentrations.
A drug, fluconazole, was subsequently introduced into the environment with C. albicans being suscep-
tible and C. glabrata resistant to it. In that case, alongside competitive exclusion and bistability, the model
also predicted coexistence as an additional outcome of competition, this has also been observed empiri-
cally [35]. Drug is absorbed and affects sensitive species (S) on a timescale relevant to the dynamics of
resource consumption and to the season lengths explored here. Whereas the relative fitness of S increases
over the growing season due to nutrient depletion, it is also impacted by the drug. In particular, the drug
has lower impact on the relative fitness of S when S is rare than when common. When S is initially rare in
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the population, R species can act as a sink for the drug in the environment (Supplementary Fig 5). There-
fore the average intracellular drug concentration per cell for S is lower in this case than when S is initially
common (Supplementary Fig 5). This, coupled with the fact that in the absence of drug S outcompetes R
at a low resource concentration, allows S to coexist with R through negative frequency dependence in the
presence of drug for sufficiently long growing seasons (see Fig 2 and Supplementary Fig 4).
The mechanism driving coexistence between sensitive and resistant Candida species identified here,
could be relevant to the coexistence of resistant and sensitive species and strains more broadly. We see
coexistence in the presence of drugs at glucose concentrations for which the sensitive species would out-
compete the resistant species in the absence of drugs. Frequently mutations that cause a sensitive strain to
become resistant are costly to growth in the absence of the drug [58], but may not reduce drug accumula-
tion rate in the presence of the drug (e.g. target modification) [59]. Therefore depending on the nature of
the cost of resistance, similar negative frequency dependent interactions to those observed by us here could
drive coexistence between sensitive and resistant strains of the same species. This mechanism differs from
that seen previously [60, 61, 62, 63] where resistance is linked to a public trait which protects the sensitive
strain. In reality, many mechanisms are likely to contribute to the maintenance of both resistance and sen-
sitivity within populations, infections, and hosts, but it is clear from the work we present that nutrients are
an important piece of the jigsaw.
Our work also suggests that the speed and therefore mode of drug action could have an impact on the
competition outcomes, in particular whether coexistence is observed. The uptake of the antifungal drug
fluconazole considered here occurs over a timescale of hours, similar to that of nutrient depletion for our
system. However, the uptake and effects of other antifungal drugs may operate over different timescales to
those of nutrient depletion, e.g. caspofungin uptake in C. albicans saturates within ⇠ 30 min [64]. Thus
an important next step would be to extend our mathematical model and explicitly model drug action and
dynamics to examine how different time scales shift or alter the observed outcomes. Nonetheless, this is a
challenging proposition, with researchers adopting a range of differing strategies [65, 66, 49, 35].
Given that nutrient depletion and drug uptake are dependent on time, it is perhaps unsurprising that
competition outcomes in our system are dependent on frequency of environmental fluctuations. However,
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we find the nature of this dependence interesting. By increasing the frequency of environmental fluc-
tuations, often termed disturbance [67], the resistance of the population can decrease, increase or remain
unchanged depending on the initial nutrient and drug concentrations in the environment. Most interestingly,
for intermediate resource concentrations and sufficiently low drug concentrations a high frequency of dis-
turbance can promote resistance (Fig 2). The empirical environmental conditions for which we validate this
result experimentally (Fig 4) mirror glucose concentrations from previous in vitro Candida studies [68, 69]
and fluconazole concentrations from previous in vitro drug-adaptation studies [70].
In our system environmental fluctuations are introduced in a similar manner done elsewhere [71, 72,
73]; after a certain period of growth the majority of the population is discarded and a small fraction is
transferred into a new environment containing replenished nutrients and drugs. In this case both the popu-
lation and ambient conditions (level of nutrient and drug concentrations), experience temporal fluctuations.
We also observe qualitatively similar theoretical outcomes in chemostat environments (seen by compar-
ing Fig 2 to Supplementary Fig 6), where the population experiences reduction in size due to mortality
events represented by a constant dilution, but changes to nutrient and drug concentrations are not manually
introduced.
The observed complex relationship between environmental fluctuations and resistance contrasts with
single species studies, where theoretically [74, 75] and empirically [26, 28, 27] it is predicted that de-
creasing the frequency of environmental fluctuations promotes evolved resistance. While environmental
fluctuations can arise from resource fluctuations, increases in drug concentration or drug switching as
well as mortality events, our findings have an important consequence. Single species antibiotic resistance
assays are a poor predictor of multi-species community dynamics as they do not take into account the
impact resources can have on the competition outcomes between sensitive and resistant species. Thus,
drug treatments designed to minimise the evolution of resistance in single-species communities, advocat-
ing ‘in general’ fast environmental change, could in a mixed-species context have undesired consequences
by promoting resistance.
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Figure Legends
Figure 1: The outcome of competition between S and R predicted by the model (5). Competition out-
comes in the presence of drug as a function of the initial nutrient concentration N and the season length T
(we set D(0) =1 µg/ml as an illustration, however the results do not qualitatively change for D(0) =0.5
or D(0) =2 µg/ml). Inside the light-blue region S wins, R wins inside the light-gray region, while ‘bistable
exclusion’ occurs in the brown region, and both species coexist in the dark-blue region. Initial population
densities are (a) 104, (b) 106, and (c) 107 cells/ml. Each axis corresponding to the initial nutrient concen-
tration is plotted from 0.95% to 1.7% glucose.
Figure 2: Theoretical dose-response mosaics describing the outcomes of competition between sensi-
tive and resistant species. Theoretical two-dimensional dose-response mosaics describing the outcomes
of competition between sensitive and resistant species at varying initial nutrient and drug concentrations
within one growing season of two different lengths: (a) short, corresponding to the high frequency of
nutrient and drug fluctuations, (b) and long, corresponding to the low frequency of nutrient and drug fluc-
tuations. Results are obtained by means of the model’s (5) simulations with the parameters values taken
from Supplementary Table 1 and the initial community density fixed at 106 cells/ml value. Each axis corre-
sponding to the initial nutrient concentration runs from 1.3% to 1.5% glucose, and each axis corresponding
to the initial drug concentration is plotted from 0 µg/ml to 12 µg/ml fluconazole. Letters A - F are for
comparison with the experimental results presented in Figure 4.
Figure 3: Theoretically generated ‘cobweb diagrams’. Population dynamics theory states that one can
deduce multi-season competition dynamics between C. albicans (S) and C. glabrata (R) from the ‘cob-
web diagrams’ determined from the initial frequency of S species plotted versus its final frequency each
season. (a) If F( f ) lies above the diagonal for all f between 0 and 1, then S wins; (b) if F( f ) lies below
the diagonal for all f between 0 and 1, then R wins; (c) if there exists a special frequency, f?, which lies
on the diagonal line, and F( f ) > f for 0 < f < f? while F( f ) < f for f? < f < 1, then the two species
coexist (for example, both starting frequencies of A and B will converge to frequency f?); (d) if there exists
a special frequency, f??, which lies on the diagonal line, and F( f ) < f for 0 < f < f?? while F( f ) > f
for f?? < f < 1, then either species can dominate depending on their initial frequencies: if the initial fre-
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quency of S is smaller than f?? (for example, for starting frequency C) then S loses out in competition to
R, otherwise R loses out (for example, for starting frequency D) - this is ‘bistable exclusion’.
Figure 4: Experimentally generated ‘cobweb diagrams’. Experimental two-dimensional dose-response
mosaic for the conditions (A, D, B) 0.05% glucose + (0, 0.5, 2) µg/ml fluconazole and (C, E, F) (0.025,
0.1, 0.5) % glucose + 0.5 µg/ml fluconazole. For each condition (shown in panels A – F) the outcome of
competition is measured for season lengths corresponding to the long and short seasons used in the math-
ematical simulations. Empirically, the short season is 6 hours in length (data shown in gold) and the long
season is 24 hours in length (data shown in red) corresponding to ⇠ 3 generations and ⇠ 5 generations of
single species growth respectively. A ‘single-season frequency change map’ with the initial frequency of C.
albicans is plotted on the x-axis and the final frequency of C. albicans – on the y-axis. Gray lines link the
average (large marker) of 3 replicate samples (small marker) and error bars are the 95% CI (confidence in-
terval). The diagonal dashed line represents no change in fraction. Gold data (B, E) is significantly below
the diagonal (significance judged at p< 0.05, two-sample, two-sided, t-test with unequal variance between
three replicate measurements of the initial fraction and three biological replicates of the final fraction) at
every initial fraction (t > 4.784, p< 0.0339, where d f = average initial fraction of S - average final fraction
of S < 0), (A, C, D, F) is significantly below the diagonal (t > 4.014, p< 0.0444) or shows no significant
deviation from the diagonal (+t < 3.077, p > 0.0547). Red data (A) all fractions are significantly above
the diagonal (t > 3.647, p < 0.0437, where d f > 0) except at an initial fraction of 0.78 (++t = 3.473,
p = 0.0673), (B) is below the diagonal at every initial fraction (t > 7.091, p < 0.0184), (C) initial frac-
tions  0.29 are significantly above the diagonal (t > 4.390, p < 0.0120), while initial fractions   0.42
do not deviate from the diagonal with any significance (t < 1.876, p > 0.242), (D) initial fractions in the
range 0.73 – 0.93 are below the diagonal (t > 4.361, p < 0.0248) while initial fractions  0.64 do not
significantly deviate from the diagonal (t < 3.020, p > 0.0535), (E) initial fractions   0.67 are signif-
icantly below the diagonal (t > 4.207, p < 0.0381), while fractions  0.47 do not deviate significantly
from the diagonal (t < 2.309, p > 0.0856), (F) initial fractions   0.45 are significantly below the diago-
nal (t > 4.622, p < 0.0178), while initial fractions  0.37 do not deviate significantly from the diagonal
(t < 3.440, p> 0.0533).
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Supplementary Information for:
Predicting community dynamics of antibiotic sensitive and resistant
species in fluctuating environments
Olga A. Nev, Alys Jepson, Robert E. Beardmore, and Ivana Gudelj
1 Parameter estimation
Yeasts can use two different pathways to produce ATP from glucose, namely respiration and fermenta-
tion [1]. C. albicans is a Crabtree-negative species [2] which deploys respiration as a glucose-utilisation
strategy, whereby most of its glucose is utilised through the tricarboxylic acid (TCA) cycle to generate
biomass and CO2 [8]. Consistent with published estimates for Crabtree-negative species [3] we fix ATP
yield per unit of glucose nATP,S = 28 pmol ATP/pmol glucose.
In contrast, C. glabrata is a Crabtree-positive species [2] which ferments most of the glucose to generate
ethanol as bi-product [8]. They produce 2 ATP per glucose in respiration and ⇠ 18 ATP per glucose in
fermentation [1]. At sufficiently low levels of oxygen and glucose, yeasts balance between fermentation
and respiration [1]. Therefore we fix ATP yield per unit of glucose nATP,R = 10 pmol ATP/pmol glucose,
as an average of ATP produced during respiration and fermentation.
The growth kinetics parameters, associated with C. albicans (C. glabrata), namelyVmax,S, Km,S, andGS
(Vmax,R, Km,R, and GR) were estimated by fitting numerical solutions of the system (5) from the main text
describing microbial population growth with XR =Dex =Din,S =Din,R = 0 (XS =Dex =Din,S =Din,R = 0)
to empirically obtained C. albicans (C. glabrata) data (Supplementary Fig 1) previously reported in [9].
Initial parameter guesses for the fitting procedures were guided by parameter estimates from the previous
study [9] deploying a similar, although more complex competition model between C. albicans and C.
glabrata.
The drug import/export and inhibition parameters for both C. albicans and C. glabrata were taken from
the literature [9].
1
All parameter values associated with the model (5) from the main text are summarised in Supplemen-
tary Table 1. Our parameterised model is subsequently able to capture previously published experimental
results presented in Fig 1 (b) in [9], demonstrating that in the absence of drug, C. albicans wins the compe-
tition at low glucose concentrations while C. glabrata wins the competition at high glucose concentrations
(see Fig 2 in the main text).
Time (h)
C
.
al
bi
ca
n
s
d
en
si
ty
(c
el
ls
/m
l)
C
.
gl
ab
ra
ta
d
en
si
ty
(c
el
ls
/m
l)
Supplementary Figure 1: Individual growth of C. albicans and C. glabrata over 24 h in 96-well plates containing the synthetic
complete (SC) medium with 2% glucose and no fluconazole. As described in [9] the plate was incubated at 30 C with shaking over
24h and growth monitored by measuring the absorbance of the cell suspensions at 650nm (A650). Absorbance units were converted
into number of cells per ml using a single fixed conversion parameter, w, with w= 1.2⇥108 for C. albicans and w= 2.2⇥108 for C.
glabrata. Left: experimental C. albicans growth data (dots, error bars are mean ± standard error, n = 3) together with the optimal
non-linear least-squares fit of the system (5) from the main text (solid curve) with XR = Dex = Din,S = Din,R = 0. Estimated growth
parameters are: Vmax,S = 0.0124395 pmol/cell/min, Km,S = 2.60284⇥ 108 pmol/ml, GS = 0.0488024 cell/pmol ATP (for datafit
statistics please see Supplementary Table 2). Right: experimental C. glabrata growth data (dots, error bars are mean± standard error,
n= 2) together with the optimal non-linear least-squares fit of the system (5) from the main text (solid curve) with XS =Dex =Din,S =
Din,R = 0. Estimated growth parameters are: Vmax,R = 0.0258526 pmol/cell/min, Km,R = 109 pmol/ml, GR = 0.215259 cell/pmol ATP
(for datafit statistics please see Supplementary Table 2). Optimal parameters values for both species are obtained usingMathematica’s
build in toolbox NonlinearModelFit.
2
Supplementary Table 1: Parameters values of the model (5) from the main text used in this study.
Parameter Biological interpretation Value Units
Growth parameters
Vmax,S maximum glucose uptake rate related to C. albicans 0.0124395 pmol/cell/min
Km,S glucose half-saturation constant related to C. albicans 2.60284⇥108 pmol/ml
nATP,S ATP yield per unit of glucose by C. albicans 28 pmol ATP/pmol glucose
GS biomass yield per unit of ATP by C. albicans 0.0488024 cell/pmol ATP
Vmax,R maximum glucose uptake rate related to C. glabrata 0.0258526 pmol/cell/min
Km,R glucose half-saturation constant related to C. glabrata 109 pmol/ml
nATP,R ATP yield per unit of glucose by C. glabrata 10 pmol ATP/pmol glucose
GR biomass yield per unit of ATP by C. glabrata 0.215259 cell/pmol ATP
Drug import parameters
Vi,S maximum fluconazole import rate related to C. albicans 6.55⇥10 9 pmol/cell/min
Ki,S fluconazole half-saturation constant related to C. albicans 6⇥104 pmol/ml
Vi,R maximum fluconazole import rate related to C. glabrata 9.8⇥10 9 pmol/cell/min
Ki,R fluconazole half-saturation constant related to C. glabrata 1.6⇥104 pmol/ml
Drug export parameters
Ve,S maximum fluconazole export rate related to C. albicans 2⇥10 11 pmol/cell/min
Ke,S fluconazole half-saturation constant related to C. albicans 5.8 pmol/ml
Ve,R maximum fluconazole export rate related to C. glabrata 3.9⇥10 11 pmol/cell/min
Ke,R fluconazole half-saturation constant related to C. glabrata 0.7 pmol/ml
Drug inhibition parameters
a relates to C. albicans fluconazole resistance properties 0.52059 dimensionless
b relates to C. albicans fluconazole resistance properties 12.001 pmol/ml
c relates to C. albicans fluconazole resistance properties 5.2347 dimensionless
2 Competition in the absence of drug
In the absence of drug, the outcome of competition between the sensitive (S) and resistant (R) competitors
depends on the initial nutrient concentration and the initial population density at the beginning of each
season as well as on the season length T (Supplementary Fig 2). Consistent with previous S-R compe-
tition models parametrised by these species [9], S outcompetes R at low nutrient concentrations, while
the opposite happens at high nutrient concentrations. Note that we are not aware of a mechanism specif-
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Supplementary Table 2: Statistics for the estimated growth parameters values
Parameter Estimate Standard Error t-Statistics P-Value
Growth parameters for C. albicans
Vmax,S 0.0124395 0.0010896 11.4166 9.08443⇥10 29
Km,S 2.60284⇥108 3.0538⇥107 8.5233 4.46797⇥10 17
GS 0.0488024 0.000115881 421.141 0
Growth parameters for C. glabrata
Vmax,R 0.0258526 0.0088575 2.91872 0.00361071
Km,R 109 3.74241⇥108 2.67208 0.00768775
GR 0.215259 0.000649799 331.27 0
ically linking resistance and better performance at high nutrient concentrations. However, these species
have different modes of metabolism of the single limiting resource they compete for, namely glucose (see
Supplementary Section 1 for details). In general, Crabtree-positive yeasts use fermentation even in the
presence of oxygen, a strategy thought to have evolved in high sugar environments around the time that
fruiting plants emerged [4, 1]. This suggests that R may have spent some of its evolutionary history in high
glucose environment, thus having higher growth rates than species S in high glucose environments (see
Supplementary Fig 3). This is also consistent with recent observations that our R species (C. glabrata) is
more frequently isolated from infections of diabetic patients with high blood sugar levels [5, 6]. Species
S has a higher growth rate than R when glucose is scarce (Supplementary Fig 3) in line with respiration
being more efficient than fermentation (Supplementary Section 1).
For a given T , we also find that increasing initial population density increases the maximal nutrient
concentrations (NS,max, black dashed line in Supplementary Fig 2) for which S outcompetes R, and in-
creases the minimal nutrient concentration (NR,min, white dashed line in Supplementary Fig 2) for which R
outcompetes S.
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Supplementary Figure 2: The outcome of competition between S and R predicted by the model (5) from the main text. Competition
outcomes in the absence of drug (namely, when D(0) = Dex = Din,S = Din,R = 0) as a function of the initial nutrient concentration N
and the season length T . Inside the light-blue region S wins, R wins inside the light-gray region, while ‘bistable exclusion’ occurs
in the brown region. The black dashed line denotes the maximal nutrient concentrations (NS,max) for which S outcompetes R, while
the white dashed line denotes the minimal nutrient concentration (NR,min) for which R outcompetes S. Initial population densities are
(a) 104, (b) 106, and (c) 107 cells/ml. The initial nutrient concentration axis is plotted from 0.95% to 1.7% glucose.
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Supplementary Figure 3: Specific growth rates of C. albicans and C. glabrata in a competition initiated at fractions 0.5:0.5 over
24 h in an initial glucose concentration of 2% without fluconazole. Results are obtained by simulating the model (5) from the main
text with parameter values from Supplementary Table 1 and an initial density of 106 cell/ml.
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In addition, both NS,max and NR,min are saturating (logistic) functions of T :
NS,max(T ) = p1,max/(1+ e p2,max(T p3,max))+ p4,max ,
NR,min(T ) = p1,min/(1+ e p2,min(T p3,min))+ p4,min ,
(1)
where two shape parameters, a mid-point location parameter p3 and a mid-point slope parameter p2, as
well as a scaling parameter p1 depend on the value of the initial inoculum, whereas an offset parameter p4
almost does not change (see Supplementary Table 3). In particular, as follows from Supplementary Table 3,
with increasing population density a scaling parameter’s value (p1) increases for both curves, whereas a
mid-point location parameter’s value (p3) decreases. This implies that sensitive species prevail at a wider
range of initial nutrient concentrations for higher population sizes. An offset parameter’s value (p4) is kept
approximately at the same level for all initial population densities as well as a mid-point slope parameter’s
value (p2) for the populations of low and intermediate sizes. The latter, however, changes dramatically
at very high population sizes, which implies that the system reaches a saturation level faster for bigger
populations.
For intermediate nutrient concentrations (between Nmax,S and Nmin,R) the system exhibits frequency-
dependent bistability whereby either S or R can outcompete each other. The size of the bistable region
depends on the initial nutrient concentration as well as on the season length T as shown in Supplementary
Fig 2. In addition, for a given T , increasing initial population density will result in an increase in the range
of initial nutrient concentrations which support bistable dynamics. This is observed by noting that for a
given T , (Nmin,R Nmax,S) increases as the initial density increases.
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Supplementary Table 3: Parameters values of Eq (1)
Parameters for the function NS,max(T )
Initial inoculum p1,max p2,max p3,max p4,max
104 cells/ml 0.144512 0.285128 44.1068 1.17486
106 cells/ml 0.294247 0.281676 21.8297 1.17894
107 cells/ml 0.501968 0.328783 11.39 1.17523
Parameters for the function NR,min(T )
Initial inoculum p1,min p2,min p3,min p4,min
104 cells/ml 0.146909 0.271046 42.1122 1.17393
106 cells/ml 0.297755 0.295111 19.5763 1.17967
107 cells/ml 0.5217 0.361761 9.48293 1.17271
3 Competition in the presence of drug
Please see Supplementary Figs 4 and 5.
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Supplementary Figure 4: Competition in the presence of drug. Theoretical two-dimensional dose-response mosaics describing the
outcomes of competition between sensitive and resistant species at varying initial nutrient and drug concentrations within one growing
season of three different lengths increasing from left to right. Results are obtained by means of simulations of the model (5) from the
main text with the parameters values taken from Supplementary Table 1 and the initial community density fixed at 106 cells/ml value.
Each axis corresponding to the initial nutrient concentration is plotted from 1.15% to 1.5% glucose, and each axis corresponding to
the initial drug concentration is plotted from 0 µg/ml to 12 µg/ml fluconazole.
4 Competition in a chemostat environment
We also investigate the behaviour of the system in a chemostat environment by changing the model (5)
from the main text the following way:8>>>>>>>>>>>>>>>>>>>>>>>>>>><>>>>>>>>>>>>>>>>>>>>>>>>>>>:
N˙(t) = d⇥ (N0 N(t)) qS(N(t))⇥XS(t) qR(N(t))⇥XR(t)
D˙ex(t) = d⇥ (Dex,0 Dex(t))+(E(Din,S(t))  I(Dex(t)))⇥XS(t)
+(E(Din,R(t))  I(Dex(t)))⇥XR(t)
D˙in,S(t) = (I(Dex(t)) E(Din,S(t)))⇥XS(t)
D˙in,R(t) = (I(Dex(t)) E(Din,R(t)))⇥XR(t)
X˙S(t) = GS⇥qS(N(t))⇥nATP,S⇥XS(t)⇥ i(Din,S(t)) d⇥XS(t)
X˙R(t) = GR⇥qR(N(t))⇥nATP,R⇥XR(t) d⇥XR(t)
t 2 [0,T ] (2)
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Supplementary Figure 5: Intracellular fluconazole accumulation (pmol/cell) for C. albicans (solid curve) and C. glabrata (dashed
curve) in competition over 24 h in an initial glucose concentration of 1.3% and 2 µg/ml fluconazole (conditions where coexistence is
predicted by the model (5) from the main text). Results are obtained by simulating the model (5) from the main text with parameter
values from Supplementary Table 1 and an initial density of 106 cell/ml.
Here, the dynamics of competition between S and R within a single season of a length T begins with
the introduction of the drug Dex,0 and the limiting nutrient N0 from the reservoir into the culture with
the dilution rate d while observing the densities of both species XS and XR in the culture. All other state
variables and parameters as well as axillary functions have a biological interpretation and a mathematical
form as in the model (5) in the main text. We further define an environmental disturbance in a chemostat
as a mass mortality, so that a disturbance to resource and drug concentrations is not manually introduced.
Supplementary Fig 6 shows very similar patterns of competition outcomes to batch culture (cf. Fig 2 in the
main text), albeit across slightly different timescales.
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Supplementary Figure 6: Theoretical two-dimensional dose-response mosaics describing the equilibrium outcomes of competition
in a chemostat environment between sensitive and resistant species at varying initial nutrient and drug concentrations within one
growing season of two different lengths: (a) short, corresponding to the high frequency of environmental disturbance, (b) and long,
corresponding to the low frequency of environmental disturbance. Results are obtained by means of simulations of the model (2)
from the supplementary text with the parameters values taken from Supplementary Table 1 and the initial community density fixed
at 106 cells/ml value. The dilution rate of a chemostat is fixed at 0.0017 per min, which is taken from an experimental study of
competition in a chemostat for glucose between Saccharomyces cerevisiae and Candida utilis that are similar microbes in terms of
their physiology and metabolism to Candida glabrata and Candida albicans, respectively [7]. Each axis corresponding to the initial
nutrient concentration is plotted from 1% to 1.5% glucose, and each axis corresponding to the initial drug concentration is plotted
from 0 µg/ml to 0.4 µg/ml fluconazole.
5 Flow cytometry
10
0.05% no fluc
2019_01_10 at 01_25_45
0.79
0.008
R2: 0.002 (9 cells)
R3: 0.998 (4717 cells)
R2: 0.992 (4873 cells)
R3: 0.008 (41 cells)
R2: 0.209 (990 cells)
R3: 0.791 (3746 cells)
A
B
1 2 3
Supplementary Figure 7: Flow cytometry. Cells were distinguished as C. albicans or C. glabrata using flow cytometry based on
differing green fluorescent protein expression. Row A shows events plotted as Forward scatter (FSC) against Side Scatter (SSC) for
samples containing (1) C. albicans only, (2) C. glabrata only, or (3) a mixture of the two species. Events were gated based on FSC
and SSC plots (R1) and then plotted as GFP intensity against SSC to separate the strains (Row B). Gates R2 for C. albicans and R3
for C. glabrata are based on the analysis of axenic cultures such that there is a false positive detection rate within the gated region
of < 3 %. Plots shown were generated using Guava InCyte software (Merck Millipore).
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